Both in Pharmaceuticals
Shattuck Labs vs CytomX Therapeutics
Over the past year STTK returned +174.9% and CTMX returned −44.5%; their daily moves had a correlation of 0.23.
STTK +174.9% CTMX −44.5%Growth of $1, one year, split-adjusted
| Metric | STTK | CTMX |
|---|---|---|
| Price | $5.47 | $2.18 |
| Market cap | $549.0M | $475.0M |
| Today | +2.82% | −2.24% |
| 1 month | −15.8% | −15.5% |
| 6 months | −16.4% | −46.6% |
| Year to date | +49.9% | −48.8% |
| 1 year | +184.9% | −38.9% |
| Revenue growth (YoY) | — | −92.4% |
| Gross margin | — | 100.0% |
| Net margin | — | −1457.4% |
| P/E (TTM) | — | — |
| Price / sales | 549.0× | 26.0× |
| Net cash | $208.3M | $330.3M |
| Dividend yield | — | — |
| Volatility (60d) | 58.5% | 67.6% |
| Short % of float | 13.2% | 21.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).